Healthcare providers may recommend treatment with Rifadin® (rifampin) for people who have tuberculosis or a certain type of bacteria called Neisseria meningitides (the bacteria that causes meningococcal infections, such as meningitis). This medicine comes in the following strengths and forms:
Rifadin 150 mg capsules
Rifadin 300 mg capsules
Rifadin 600 mg for injection.
The medication can also be made into a liquid suspension for people who have difficulty swallowing the capsules, such as children. Side effects are possible and include headaches, drowsiness, and a loss of appetite.
(Click Rifadin for more information on this antibiotic. This article takes an in-depth look at how this drug works, how it is taken, and why it may not be suitable for some people.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed May 23, 2013.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed May 24, 2013.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
National Library of Medicine (US). Hazardous Substances Data Bank (HSDB). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed May 24, 2013.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click